Preparation and Characterisation of Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment
Zinc diethyldithiocarbamate (Zn (DDC)<sub>2</sub>), a disulfiram metabolite (anti-alcoholism drug), has shown a strong anti-cancer activity in vitro. However, its application was limited by its low aqueous solubility and rapid metabolism. In this study, the solubility enhancement of Zn (...
Main Authors: | Ayşe Kaya, Basel Arafat, Havovi Chichger, Ibrahim Tolaymat, Barbara Pierscionek, Mouhamad Khoder, Mohammad Najlah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/1/65 |
Similar Items
-
olubility Enhancement for Dietheyldithiocarbamate-Zinc for Lung Cancer Treatment
by: Ayse Kaya, et al.
Published: (2022-11-01) -
Development of Liposomal Formulations of Zinc Diethyldithiocarbamate for Colorectal Cancer Treatment
by: Niusha Ansari-Fard, et al.
Published: (2022-11-01) -
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
by: Ammar Said Suliman, et al.
Published: (2021-01-01) -
Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation
by: Abeer A. El-Saharty, et al.
Published: (2015-12-01) -
Preparation and Characterization of Disulfiram and Beta Cyclodextrin Inclusion Complexes for Potential Application in the Treatment of SARS-CoV-2 via Nebulization
by: Ana Maria Pereira, et al.
Published: (2022-08-01)